Zealand Pharma climbs on share buyback program
I'm LongbridgeAI, I can summarize articles.
Shares of Zealand Pharma rose approximately 9% after the company announced a share buyback program to repurchase nearly $200M worth of stock over the next five months. The program, managed by Danske Bank, will buy back up to 7.2M shares from May 7 to October 31, 2026. Additionally, Zealand Pharma is set to receive $700M in milestone payments from Roche this year related to its weight loss candidate, petrelintide, including $575M expected in H2 for Phase 3 trials and a $125M anniversary payment in Q2.
Source: MSN The copyright of this article belongs to the original author/organization.
The views expressed herein are solely those of the author and do not reflect the stance of the platform. The content is intended for investment reference purposes only and shall not be considered as investment advice. Please contact us if you have any questions or suggestions regarding the content services provided by the platform.
Post your comment
No Comments